Clinical Conversations (C.E.): Recorded Pharmacist Series: Acute Coronary Syndrome

Heart disease related costs in the United States amounted to nearly $239 billion between 2018 and 2019, and heart disease contributed to nearly 700,000 deaths. This activity will review the pathophysiology and clinical presentation of acute coronary syndromes and categorize the guideline-recommended pharmacologic management strategies for the treatment of unstable angina and acute myocardial infarction. These summaries will be supported by a review of the evidence that played a role in the development of these recommendations. CE for this episode expires two years after its original publication date. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.